Cartesian Therapeutics Stock Forecast

Hold candidate since Aug 10, 2026

The Cartesian Therapeutics, Inc. stock price fell by -1.02% on the last day (Monday, 10th Aug 2026) from $8.85 to $8.76. During the last trading day the stock fluctuated 3.07% from a day low at $8.64 to a day high of $8.91. The price has risen in 7 of the last 10 days and is up by 12.45% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -34 thousand shares and in total, 50 thousand shares were bought and sold for approximately $441.63 thousand.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 15.48% during the next 3 months and, with a 90% probability hold a price between $7.98 and $12.96 at the end of this 3-month period.

RNAC Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, July 29, 2026, and so far it has risen 18.06%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Cartesian Therapeutics, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $8.87. On a fall, the stock will find some support from the short-term average at $8.35. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Cartesian Therapeutics, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $8.06 and $7.43. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Cartesian Therapeutics, Inc. finds support just below today's level at $8.06. If this is broken, then the next support from accumulated volume will be at $7.43 and $6.85.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.265 between high and low, or 3.07%. For the last week the stock has had daily average volatility of 5.52%.

Our recommended stop-loss: $8.43 (-3.72%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 8 days ago.)

Trading Expectations (RNAC) For The Upcoming Trading Day Of Tuesday 11th

For the upcoming trading day on Tuesday, 11th we expect Cartesian Therapeutics, Inc. to open at $8.77, and during the day (based on 14 day Average True Range), to move between $8.48 and $9.04, which gives a possible trading interval of +/-$0.551 (+/-6.50%) up or down from last closing price. If Cartesian Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 6.50% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $9.42 (7.53%) than the support at $8.06 (7.99%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Cartesian Therapeutics, Inc. stock A Buy?

Cartesian Therapeutics, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.

Current score: -0.400 Hold/Accumulate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on August 11, 2026 - $8.77 ( 0.0951%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk